Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE198H01019
Sector:
Healthcare
Symbol:
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Limited
₹35.86
₹2.32
(6.92%)
▲
Prev. Close
₹33.54
Open
₹34.80
Close
₹35.21
Range
₹34.07 - ₹37.65
High
₹35.98
Low
₹33.62
Ind. Close
₹0.00
VWAP
₹34.95
The current stock price of Aarey Drugs & Pharmaceuticals Limited is ₹35.86, with a target price range between ₹34.07 and ₹37.65. The stock has experienced a price change of ₹2.32 (6.92%), reflecting recent market volatility.
Today's opening price was ₹34.80, while the previous close stood at ₹33.54.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Aarey Drugs & Pharmaceuticals Limited Price Chart
Aarey Drugs & Pharmaceuticals Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 34.8
- Previous Close Price: 33.54
- Change: 1.26%
- Total Traded Volume: 24
- Total Buy Quantity: 6,234
- Total Sell Quantity: 12,874
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 33.00 | 31.00 | 0.00 |
| 33.20 | 100.00 | 0.00 |
| 33.23 | 200.00 | 0.00 |
| 33.25 | 200.00 | 0.00 |
| 33.54 | 10.00 | 0.00 |
| 34.80 | 0.00 | 9,976.00 |
| 34.96 | 0.00 | 100.00 |
| 34.97 | 0.00 | 50.00 |
| 34.99 | 0.00 | 248.00 |
| 35.49 | 0.00 | 50.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 6234
Total Sell Quantity: 12874
Shareholding Patterns of Aarey Drugs & Pharmaceuticals Limited
Key Trade Statistics of Aarey Drugs & Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.44 |
| Traded Value (₹ Cr.) | 0.15 |
| Total Market Cap (₹ Cr.) | 101.68 |
| Free Float Market Cap (₹ Cr.) | 53.77 |
| Impact cost | 2.46 |
| Quantity Traded | 44,069.00 |
| Deliverable Quantity | 29,841.00 |
| % of Quantity to Traded | 67.71 |
| Security VaR | 19.28 |
| Index VaR | N/A |
| VaR Margin | 21.5 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25 |
| Face Value | 10 |
Key Price Statistics of Aarey Drugs & Pharmaceuticals Limited
The 52-week high for Aarey Drugs & Pharmaceuticals Limited was ₹74.80, recorded on 05-Sep-2024. On the other hand, the 52-week low stands at ₹31.35, with the lowest value recorded on 18-Mar-2025.
The upper band for trading is ₹36.89, and the lower band is ₹30.18. The price band is 10%.
The stock's daily volatility stands at 2.94, while the annualized volatility is 56.17. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (05-Sep-2024) | 74.80 |
| 52 Week Low (18-Mar-2025) | 31.35 |
| Upper Band | 36.89 |
| Lower Band | 30.18 |
| Price Band (%) | 10 |
| Daily Volatility | 2.94 |
| Annualised Volatility | 56.17 |
| Tick Size | 0.01 |
Key Securities Statistics of Aarey Drugs & Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 06-Aug-2021 |
| Adjusted P/E | 16.67 |
| Symbol P/E | 16.67 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Aarey Drugs & Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Aarey Drugs & Pharmaceuticals Limited
| Subject | Date |
|---|---|
| No announcements available | |
Corporate Actions of Aarey Drugs & Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 23-Sep-2024 |
| 10 | Annual General Meeting | 29-Aug-2023 |
| 10 | Annual General Meeting | 22-Sep-2022 |
| 10 | Annual General Meeting | 02-Sep-2021 |
Board Meetings of Aarey Drugs & Pharmaceuticals Limited
Financial Results of Aarey Drugs & Pharmaceuticals Limited
Company Directory of Aarey Drugs & Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 1227, Hubtown Solaris, N.S. Phadke Marg Opp. Telli Galli, Andheri Flyover Bridge Andheri - East | MUMBAI |
| N/A | Registered Office | E-34, M.I.D.C, Tarapur | BOISAR |
| N/A | Transfer Agent | C-101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai, Maharashtra - 400083 | MUMBAI |
Insider Trading of Aarey Drugs & Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Chetan Mehta | 12348000 | Buy |
| 7(2) | Bina Rajesh Ghatalia | 6174000 | Buy |
| 7(2) | Mira Mihir Ghatalia | 10290000 | Buy |
| 7(2) | Nimit Rajesh Ghatalia | 6174000 | Buy |
| 7(2) | Nimit Impex Pvt Ltd | 2058000 | Buy |
| 7(2) | Suraj Tradelinks Pvt Ltd | 2058000 | Buy |
Annual Reports of Aarey Drugs & Pharmaceuticals Limited
Investor Complaints of Aarey Drugs & Pharmaceuticals Limited
Event Calendar of Aarey Drugs & Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Fund Raising | Intimation for Board Meeting. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Fund Raising | To consider Fund Raising |
| Fund Raising | To consider Fund Raising |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Aarey Drugs & Pharmaceuticals Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 31-MAR-2024 | ||
| Aarey Drugs & Pharmaceuticals Limited | 31-MAR-2023 | ||
| Aarey Drugs & Pharmaceuticals Limited | 31-MAR-2022 |
Voting Results of Aarey Drugs & Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 02-JAN-2025 | EGM | 1. Issue of 50,00,000 Convertible Warrants on Preferential basis |
| 02-JAN-2025 | EGM | Re-appointment of Mr. Anil Mandal (DIN: 08291619) as an Independent Director: |
| 02-JAN-2025 | EGM | Re-appointment of Mr. Lalit Tulsiani (DIN: 01652630) as an Independent Director: |
| 02-JAN-2025 | EGM | 1. Issue of 50,00,000 Convertible Warrants on Preferential basis |
| 02-JAN-2025 | EGM | Re-appointment of Mr. Anil Mandal (DIN: 08291619) as an Independent Director: |
| 02-JAN-2025 | EGM | Re-appointment of Mr. Lalit Tulsiani (DIN: 01652630) as an Independent Director: |
| 30-SEP-2024 | AGM | 1. Audited Financial Statement of the Company for the year ended 31st March, 2024, along with Director￢ﾀﾙs Report and Auditor￢ﾀﾙs Report thereon |
| 30-SEP-2024 | AGM | Approval of loan(s), investment(s), guarantee(s) or security(ies) under Section 185 of the Companies Act, 2013 up to Rs. 200 Crores |
| 30-SEP-2024 | AGM | 2. To appoint a Director in place of Mr. Mihir Ghatalia (DIN: 00581005), who retires by rotation and being eligible, offers himself for re-appointment. |
| 29-DEC-2023 | EGM | Reappointment of Mr. Mihir Ghatalia (DIN: 00581005) as Chairman and managing Director of the Company |
| 29-DEC-2023 | EGM | To regularise the appointment of Mrs. Bina Ghatalia (DIN: 01471745) as Non ￢ﾀﾓ Executive Director of the Company |
| 05-SEP-2023 | AGM | 1. To receive, consider and adopt the Audited Financial Statement of the Company for the year ended 31st March, 2023, the Balance sheet as on that date and the reports of Directors and Auditors thereon. |
| 05-SEP-2023 | AGM | Consent of Members to increase in the limits applicable for making investmentsn/extending loans and giving guarantees or providing securities in connection with loans to Persons / Bodies Corporatenn |
| 05-SEP-2023 | AGM | Approval of loan by the Company in terms of provision of section 185 of the Companies act 2013 |
| 05-SEP-2023 | AGM | Creation of Charge over the Assets of the Company |
| 05-SEP-2023 | AGM | Increase in Borrowing Power of Company |
| 05-SEP-2023 | AGM | Issue of 50,00,000 Convertible Warrants on Preferential basis |
| 05-SEP-2023 | AGM | Issue Upto 50,00,000 Equity Shares on a Preferential Basis |
| 05-SEP-2023 | AGM | Increase in Authorised Share Capital and consequential alteration of Capital Clause of the Memorandum of Association |
| 05-SEP-2023 | AGM | To appoint a Director in place of Mr. Mihir Ghatalia (DIN: 00581005), who retires by rotation and being eligible, offers himself for re-appointment. |
FAQs on Aarey Drugs & Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.